Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone vs Methylprednisolone in Mandibular Parasymphysis Fractures
NCT07208799Phase 2Recruiting
- Sponsor
- Nishtar Medical University
- Start
- Jan 2026
- Primary completion
- Nov 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in mandibular fracture comparing Dexamethasone group with Methylprednisolone group (2 arms). Primary endpoints: Facial Edema at 72 hours and Pain intensity at 72 hours. Started Jan 2026; status: recruiting.
02
Drugs
dexamethasonemethylprednisolone
03
Conditions
mandibular fracture
Beyond the preview
Go deeper on NCT07208799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07208799.